# A Second Study of NicVAX/Placebo as an Aid for Smoking Cessation

> **NCT01102114** · PHASE3 · COMPLETED · sponsor: **Nabi Biopharmaceuticals** · enrollment: 1000 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **BIOLOGICAL:** NicVAX Vaccine
- **BIOLOGICAL:** Placebo Vaccine

## Key facts

- **NCT ID:** NCT01102114
- **Lead sponsor:** Nabi Biopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2012-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01102114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01102114, "A Second Study of NicVAX/Placebo as an Aid for Smoking Cessation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01102114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*